Pharmaceuticals

AstraZeneca CFO Leaves

 

AstraZeneca(AZN) said Wednesday that CFO Jon Symonds will leave at the end of July to become a managing director at Goldman Sachs(GS).

The search for his successor is in progress.

Symonds joins the parade of drug industry CFOs leaving their companies. This year, financial chiefs at Pfizer(PFE), Amgen(AMGN), Wyeth(WYE) and Merck(MRK) have left their jobs or have announced their departures.

Last year, Eli Lilly (LLY)and Johnson & Johnson(JNJ) hired new CFOs.

Symonds had been with AstraZeneca and a predecessor company for 10 years. Having spent 17 years at the accounting firm KPMG, he joined the British drugmaker Zeneca as CFO in 1997. When Zeneca merged with Sweden's Astra in 1998, he became the financial chief of the combined company.

His resignation was announced on the same day that AstraZeneca said it had completed its tender offer for shares of MedImmune(MEDI). AstraZeneca expects to complete the $15.6 billion acquisition on June 18.

>To order reprints of this article, click here: Reprints

TheStreet Premium Services

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
Dow Jones S&P 500 NASDAQ 10-Year Note
12,393.45 1,310.33 2,827.34 15.81
Oil *
101.78
DOWN
26.41
DOWN
2.99
DOWN
10.02
DOWN
0.44
10 Yr
1.58%
SPDR Gold
151.62
-0.21%
-0.23%
-0.35%
-2.71%
Data delayed 20 minutes

Top Stories and Tools

Articles From

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Podcasts

Connect with TheStreet